Preferences help
enabled [disable] Abstract
Number of results
2018 | 21 | 2 | 43-47
Article title

Environmental risk factors for bladder cancer

Title variants
Środowiskowe czynniki ryzyka rozwoju raka pęcherza moczowego
Languages of publication
Bladder cancer is a disease characterized by an abnormal growth of cells in the urinary bladder. Potentially, it can infiltrate nearby tissues and metastasize to distant organs. It affects more than 3 million people, with over 430,000 new cases a year. Environmental risk factors have significant impact on the development of bladder cancer, with tobacco smoke being the single most significant risk factor. Arsenic, nitrates, and chlorine in drinking water are also potentially associated with an elevated risk of this disease. In this paper, we review most significant environmental risk factors for primary bladder cancer and analyze prevention methods.
Rak pęcherza moczowego jest schorzeniem charakteryzującym się nieprawidłowym wzrostem komórek w pęcherzu moczowym. Potencjalnie może naciekać okoliczne tkanki i dawać przerzuty do odległych narządów. Rak pęcherza moczowego dotyka ponad 3 miliony ludzi na świecie, a co roku diagnozowanych jest ponad 430 tysięcy nowych przypadków. Środowiskowe czynniki ryzyka mają znaczący wpływ na rozwój raka pęcherza. Dym papierosowy jest czynnikiem ryzyka o największym znaczeniu. Arsen, azotany i związki chloru zawarte w wodzie pitnej są prawdopodobnie związane z podwyższonym ryzykiem raka pęcherza moczowego. Celem tego artykułu jest przegląd środowiskowych czynników ryzyka pierwotnego raka pęcherza moczowego oraz analiza metod zapobiegania.
  • Department of Urology and Oncological Urology, Wroclaw Medical University
  • [1] Ferlay J., Soerjomataram I., Ervik M., et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Available from:, accessed on 5/12/2017.
  • [2] Wojciechowska U., Didkowska J.: Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie. Available from: on 5/12/2017.
  • [3] Abdollah F., Gandaglia G., Thuret R. et al.: Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis. Cancer Epidemiology 2013; 37: 219–225.
  • [4] Freedman N.D., Silverman D.T., Hollenbeck A.R., Schatzkin A., Abnet C.C.: Association Between Smoking and Risk of Bladder Cancer Among Men and Women. JAMA 2011; 306: 737.
  • [5] Baris D., Karagas M.R., Verrill C. et al.: A case-control study of smoking and bladder cancer risk: emergent patterns over time. Journal of the National Cancer Institute 2009; 101: 1553–1561.
  • [6] Besaratinia A., Tommasi S.: Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions. The FASEB Journal 2013; 27: 2090–2100.
  • [7] Peppone L.J., Reid M.E., Moysich K.B. et al.: The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer causes & control : CCC 2010; 21: 1247–1255.
  • [8] Asomaning K., Miller D.P., Liu G. et al.: Second hand smoke, age of exposure and lung cancer risk. Lung cancer (Amsterdam, Netherlands) 2008; 61: 13–20.
  • [9] Nieder A.M., John S., Messina C.R., Granek I.A., Adler H.L.: Are Patients Aware of the Association Between Smoking and Bladder Cancer? The Journal of Urology 2006; 176: 2405–2408.
  • [10] Yuruk E., Tuken M., Colakerol A., Serefoglu E.C.: The awareness of patients with non – muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs. International braz jurol : official journal of the Brazilian Society of Urology 43: 607–614.
  • [11] Silvera S.A.N., Rohan T.E.: Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes & Control 2007; 18: 7–27.
  • [12] Hong Y.-S., Song K.-H., Chung J.-Y.: Health effects of chronic arsenic exposure. Journal of preventive medicine and public health = Yebang Uihakhoe chi 2014; 47: 245–252.
  • [13] Fernández M.I., López J.F., Vivaldi B., Coz F.: Long-Term Impact of Arsenic in Drinking Water on Bladder Cancer Health Care and Mortality Rates 20 Years After End of Exposure. The Journal of Urology 2012; 187: 856–861.
  • [14] Steinmaus C., Yuan Y., Bates M.N., Smith A.H.: Case-control study of bladder cancer and drinking water arsenic in the western United States. American journal of epidemiology 2003; 158: 1193–1201.
  • [15] Chiu H.-F., Tsai S.-S., Yang C.-Y.: Nitrate in Drinking Water and Risk of Death from Bladder Cancer: An Ecological CaseControl Study in Taiwan. Journal of Toxicology and Environmental Health, Part A 2007; 70: 1000–1004.
  • [16] Ward M.H., Cantor K.P., Riley D., Merkle S., Lynch C.F.: Nitrate in Public Water Supplies and Risk of Bladder Cancer. Epidemiology 2003; 14: 183–190.
  • [17] Zeegers M.P., Selen R.F.M., Kleinjans J.C.S., Goldbohm R.A., van den Brandt P.A.: Nitrate intake does not influence bladder cancer risk: the Netherlands cohort study. Environmental health perspectives 2006; 114: 1527–1531.
  • [18] Villanueva C.M., Fernández F., Malats N., Grimalt J.O., Kogevinas M.: Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. Journal of epidemiology and community health 2003; 57: 166–173.
  • [19] Felknor S.A., Delclos G.L.: An Updated Review of the Literature: Risk Occupational Exposures. Southern Medical Journal 2006; 1256–1264.
  • [20] Pira E., Piolatto G., Negri E. et al.: Bladder Cancer Mortality of Workers Exposed to Aromatic Amines: A 58-Year Follow-up. JNCI: Journal of the National Cancer Institute 2010; 102: 1096–1099.
  • [21] Lokeshwar S., Klaassen Z., Terris M.: A Contemporary Review of Risk Factors for Bladder. Clinics in Oncology 2016; 1: 1–3.
  • [22] Tsai R.J., Luckhaupt S.E., Schumacher P. et al.: Risk of cancer among firefighters in California, 1988-2007. American journal of industrial medicine 2015; 58: 715–729.
  • [23] Fent K.W., Eisenberg J., Snawder J. et al.: Systemic exposure to PAHs and benzene in firefighters suppressing controlled structure fires. The Annals of occupational hygiene 2014; 58: 830–845.
  • [24] Giedl J., Rogler A., Wild A. et al.: TERT Core Promotor Mutations in Early-Onset Bladder Cancer. Journal of Cancer 2016; 7: 915–920.
  • [25] Malats N., Bustos A., Nascimento C.M. et al.: P53 as a prognostic marker for bladder cancer: a meta-analysis and review. The Lancet Oncology 2005; 6: 678–686.
  • [26] Borkowska E., Binka-Kowalska A., Constantinou M. et al.: P53 mutations in urinary bladder cancer patients from Central Poland. Journal of Applied Genetics 2007; 48: 177–183.
  • [27] Lee K.-H., Song C.G.: Epigenetic regulation in bladder cancer: development of new prognostic targets and therapeutic implications. Translational Cancer Research 2017; 6: 677–688.
  • [28] Wojtczyk-Miaskowska A., Presler M., Michajlowski J., Matuszewski M., Schlichtholz B.: Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer. Cellular Physiology and Biochemistry 2017; 42: 2404–2417.
  • [29] Szymańska B., Sawicka E., Guzik A., Zdrojowy R., Długosz A.: The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens. BioMed Research International 2017; 2017: 1–11.
  • [30] Szymańska B., Pawlik K., Sawicka E. et al.: Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins. Advances in Clinical and Experimental Medicine 2017; 26: 1069-1075.
  • [31] Mostafa M.H., Sheweita S.A., O’Connor P.J.: Relationship between schistosomiasis and bladder cancer. Clinical microbiology reviews 1999; 12: 97–111.
  • [32] Rambau P.F., Chalya P.L., Jackson K.: Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients. Infectious agents and cancer 2013; 8: 19.
  • [33] Keimling M., Behrens G., Schmid D., Jochem C., Leitzmann M.F.: The association between physical activity and bladder cancer: Systematic review and meta-analysis. British Journal of Cancer 2014; 110: 1862–1870.
  • [34] Park S., Ollberding N.J., Woolcott C.G. et al.: Fruit and Vegetable Intakes Are Associated with Lower Risk of Bladder Cancer among Women in the Multiethnic Cohort Study 1, 2. 2013; 1283–1292.
  • [35] Al-Zalabani A.H., Stewart K.F.J., Wesselius A., Schols A.M.W.J., Zeegers M.P.: Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. European Journal of Epidemiology 2016; 31: 811–851.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.